WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia
Biden to travel to North Carolina to meet with families of officers killed in deadly shooting
New US sanctions against Russia target weapons development, ban uranium imports for nuclear power
Lightning coach Jon Cooper apologizes for inappropriate comment about putting skirts on goalies
‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
Tom Cruise 'hires hawks' to prevent pigeon chaos during Mission Impossible 8 filming in London
Kim Kardashian shows off her curves and continues to plug controversial $60k Cybertruck
Ross Stripling earns his first win since 2022 as Athletics blank Pirates 4
Devout Christian doctor, 68, who punched dementia
Georgia governor signs law requiring jailers to check immigration status of prisoners